Koshinski Asset Management Inc. Has $346,000 Stock Position in Colgate-Palmolive (NYSE:CL)

Koshinski Asset Management Inc. lowered its holdings in Colgate-Palmolive (NYSE:CLGet Rating) by 8.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,320 shares of the company’s stock after selling 413 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Colgate-Palmolive were worth $346,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $649,161,000. BlackRock Inc. lifted its position in shares of Colgate-Palmolive by 8.4% during the 4th quarter. BlackRock Inc. now owns 65,218,485 shares of the company’s stock worth $5,565,745,000 after buying an additional 5,039,853 shares during the period. Renaissance Technologies LLC lifted its position in shares of Colgate-Palmolive by 151.6% during the 1st quarter. Renaissance Technologies LLC now owns 5,688,786 shares of the company’s stock worth $431,381,000 after buying an additional 3,427,400 shares during the period. Caisse DE Depot ET Placement DU Quebec lifted its position in shares of Colgate-Palmolive by 1,915.2% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,793,287 shares of the company’s stock worth $135,985,000 after buying an additional 1,704,300 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in shares of Colgate-Palmolive by 1,334.0% during the 1st quarter. Assenagon Asset Management S.A. now owns 999,783 shares of the company’s stock worth $75,814,000 after buying an additional 930,063 shares during the period. Institutional investors and hedge funds own 78.62% of the company’s stock.

Colgate-Palmolive Stock Performance

CL opened at $75.36 on Friday. Colgate-Palmolive has a 52-week low of $72.20 and a 52-week high of $85.61. The firm has a market capitalization of $62.86 billion, a PE ratio of 32.62, a PEG ratio of 5.38 and a beta of 0.48. The company has a debt-to-equity ratio of 14.26, a quick ratio of 0.72 and a current ratio of 1.17. The business’s 50-day simple moving average is $78.86 and its 200 day simple moving average is $78.05.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its earnings results on Friday, July 29th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. Colgate-Palmolive had a return on equity of 315.10% and a net margin of 10.98%. The company had revenue of $4.48 billion for the quarter, compared to the consensus estimate of $4.35 billion. During the same quarter in the prior year, the business earned $0.80 earnings per share. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.03 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Friday, October 21st will be given a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Thursday, October 20th. Colgate-Palmolive’s payout ratio is 81.39%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Wells Fargo & Company upgraded Colgate-Palmolive to an “equal weight” rating in a research report on Tuesday, August 9th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $79.00 to $78.00 in a research report on Thursday, July 21st. Barclays lifted their target price on Colgate-Palmolive from $71.00 to $74.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 2nd. Deutsche Bank Aktiengesellschaft lowered their target price on Colgate-Palmolive from $88.00 to $87.00 in a research note on Tuesday, July 19th. Finally, UBS Group lifted their target price on Colgate-Palmolive from $88.00 to $90.00 and gave the company a “buy” rating in a research note on Monday, August 1st. Thirteen analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $84.57.

Insider Buying and Selling

In other Colgate-Palmolive news, insider Jennifer Daniels sold 24,703 shares of the company’s stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the completion of the sale, the insider now directly owns 48,163 shares in the company, valued at $3,913,243.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Jennifer Daniels sold 24,703 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the completion of the transaction, the insider now owns 48,163 shares in the company, valued at approximately $3,913,243.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 656 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $77.58, for a total transaction of $50,892.48. Following the completion of the sale, the insider now directly owns 7,913 shares in the company, valued at approximately $613,890.54. The disclosure for this sale can be found here. Insiders have sold 125,802 shares of company stock valued at $10,100,532 over the last 90 days. 0.32% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLGet Rating).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.